Suppr超能文献

雄激素受体基因中的多态性CAG重复序列、前列腺特异性抗原多态性与前列腺癌风险

Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.

作者信息

Gsur Andrea, Preyer Martin, Haidinger Gerald, Zidek Thomas, Madersbacher Stephan, Schatzl Georg, Marberger Michael, Vutuc Christian, Micksche Michael

机构信息

Division of Applied and Experimental Oncology, Institute of Cancer Research, University of Vienna, Austria.

出版信息

Carcinogenesis. 2002 Oct;23(10):1647-51. doi: 10.1093/carcin/23.10.1647.

Abstract

As the development of prostate cancer is androgen-dependent, it has been hypothesized that variation in transcriptional activity by the androgen receptor (AR) related to polymorphic CAG repeats in exon 1, influences prostate cancer risk. The AR regulates gene transcription by binding to androgen-response elements (AREs) in target genes, such as the prostate-specific antigen (PSA). In the ARE-I sequence of the PSA gene an adenine to guanine polymorphism is described. It has been hypothesized that the AR binds the two PSA alleles (A and G) with differing affinities and may, thereby, differentially influence prostate cancer risk. To examine the role of the polymorphisms in the AR and PSA genes in prostate cancer susceptibility, we conducted a case-control study of Austrian Caucasians with 190 newly diagnosed prostate cancer patients and 190 age-matched control men with benign prostatic hyperplasia (BPH). The polymorphisms were determined by polymerase chain reaction (PCR)-based methods using DNA from peripheral white blood cells. Logistic regressions were performed to calculate odds ratios (OR) and confidence limits (CL) and to control for possible confounders. Our data provide no evidence for an association between prostate cancer and CAG repeat length. However, we found a significant influence of the ARE-I PSA polymorphism on prostate cancer risk, when calculating the combination of the A/G and G/G genotypes relative to subjects with the A/A genotype (OR = 0.63; 95% CL 0.39-0.99; P = 0.048), suggesting that the G allele has a protective effect. In a case analysis according to Gleason score, the PSA G/G genotype was significantly more frequent in patients with Gleason score >7 (35.1%) than in patients with Gleason score <7 (21.5%), providing evidence that the PSA G/G genotype is associated with more advanced disease at time of diagnosis. However, the ambivalent role of the PSA during prostate carcinogenesis needs further investigation.

摘要

由于前列腺癌的发展依赖雄激素,因此有假说认为,雄激素受体(AR)的转录活性变化与外显子1中多态性CAG重复序列相关,会影响前列腺癌风险。AR通过与靶基因(如前列腺特异性抗原,PSA)中的雄激素反应元件(AREs)结合来调节基因转录。在PSA基因的ARE-I序列中,描述了一种腺嘌呤到鸟嘌呤的多态性。有假说认为,AR以不同亲和力结合两个PSA等位基因(A和G),从而可能对前列腺癌风险产生不同影响。为了研究AR和PSA基因多态性在前列腺癌易感性中的作用,我们对奥地利高加索人进行了一项病例对照研究,其中包括190名新诊断的前列腺癌患者和190名年龄匹配的良性前列腺增生(BPH)对照男性。使用外周血白细胞的DNA,通过基于聚合酶链反应(PCR)的方法确定多态性。进行逻辑回归以计算比值比(OR)和置信区间(CL),并控制可能的混杂因素。我们的数据没有提供前列腺癌与CAG重复长度之间存在关联的证据。然而,在计算A/G和G/G基因型相对于A/A基因型受试者的组合时,我们发现ARE-I PSA多态性对前列腺癌风险有显著影响(OR = 0.63;95% CL 0.39 - 0.99;P = 0.048),表明G等位基因具有保护作用。在根据Gleason评分进行的病例分析中,Gleason评分>7的患者中PSA G/G基因型的频率(35.1%)显著高于Gleason评分<7的患者(21.5%),这证明PSA G/G基因型与诊断时更晚期的疾病相关。然而,PSA在前列腺癌发生过程中的矛盾作用需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验